Bioinformatics News May 2008: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 5 Next

OGT's miRNA Profiling Service Provides Rapid Answers For Disease Research
Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, is pleased to announce the launch of a new microRNA (miRNA) profiling service designed to help researchers accelerate their discoveries (Tue, 13 May 2008 13:03:17 GMT)

New Ludesi REDFIN 2D Gel Image Analysis Software Upgrade Enables Experiment Sharing and Collaboration Worldwide
Ludesi Corporation, developer of the award-winning Ludesi Image Analysis Service for 2-dimensional electrophoresis gels, today announced version 2.0 of its REDFIN Image and Data Management software. The new version allows researchers to easily share their Ludesi analyzed experiments with colleagues around the world simply by clicking on a "share" button and entering the email address of the ... (Tue, 13 May 2008 13:30:00 GMT)

Genetic links to impaired social behavior in autism
Philadelphia, PA, May 13, 2008 – Individuals with autism spectrum disorders (ASD) show profound deficits in social interactions and communications, and display repetitive behaviors and abnormal responses to sensory experiences. (Tue, 13 May 2008 13:50:45 GMT)

Researchers discover architecture for fundamental processes of life
Montreal, May 13, 2008 – A team of Canadian researchers has completed a massive survey of the network of protein complexes that orchestrate the fundamental processes of life. (Tue, 13 May 2008 14:20:40 GMT)

Genetic Links To Impaired Social Behavior In Autism
Individuals with autism spectrum disorders show profound deficits in social interactions and communications and display repetitive behaviors and abnormal responses to sensory experiences. One aspect of an autistic child's impaired social abilities is their lack of affiliative behaviors, i.e., behaviors such as touching and hugging that strengthen social bonds. (Tue, 13 May 2008 15:11:46 GMT)

Architecture For Fundamental Processes Of Life Discovered
Researchers have completed a massive survey of the network of protein complexes that orchestrate the fundamental processes of life. In the journal Science, researchers describe protein complexes and networks of complexes never before observed -- including two implicated in the normal mechanisms by which cells divide and proliferate and another that controls recycling of the molecular building ... (Tue, 13 May 2008 15:12:47 GMT)

The Blue Revolution, Drop by Drop, Gene by Gene
This article discusses efforts to develop new crop varieties with enhances drought tolerance. "Drought and tolerance to water stress are very hot topics at this moment," says Roberto Tuberosa of the University of Bologna in Italy, and there's been "a constant increase in interest, particularly from the private sector." (Tue, 13 May 2008 15:30:22 GMT)

Ceres Inc. makes effort to develop new bioenergy crops
As the food versus fuel conversation continues, forward-looking companies and individuals are finding ways to supply both food and energy. A genomics technology firm, Ceres, Inc., is making a big effort to develop new bioenergy crops. (Tue, 13 May 2008 18:03:52 GMT)

Identification of Molecular Markers for Endometriosis in Blood Lymphocytes Using DNA Microarrays
Endometriosis is a common, non-malignant gynecological disease that affects up to 20% of women during their reproductive years. Endometriosis is characterized by the growth of endometrial tissue outside the uterus. This growth of tissue causes recurring severe pain and can lead to infertility. (Tue, 13 May 2008 18:13:20 GMT)

Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs
Sigma-Aldrich is pleased to announce that BioInformatics, LLC, a leading market research company for the life science industry, reports that the Company's online product catalog is considered by scientists to be "most useful" and "easiest to use". (Tue, 13 May 2008 20:15:00 GMT)

Got a sweet tooth? Turns out it could all be in your genes
TORONTO - For those who have a sweet tooth and wonder why they're so drawn to sugary foods and beverages, the answer could be that it's all in the genes. (Wed, 14 May 2008 04:21:00 GMT)

QIAGEN and GENEART Partner to Commercialize Synthetic Mammalian Genes
- Complete set of mammalian genes is optimized & produced by GENEART and sold via QIAGEN's GeneGlobe web portal (Wed, 14 May 2008 06:00:00 GMT)

QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes
Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development (Wed, 14 May 2008 06:00:00 GMT)

QIAGEN and GENEART Partner to Commercialize Synthetic Mammalian Genes
n-tv.de - Ständig aktuelle Nachrichten (Wed, 14 May 2008 06:14:23 GMT)

QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes
Venlo, The Netherlands --- May 14, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and GENEART (Frankfurt, Entry Standard, G6A) announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins. (Wed, 14 May 2008 06:14:45 GMT)

DJ HUGIN NEWS/QIAGEN and GENEART Partner to Commercialize Synthetic Human Genes
Joint development and collaboration enables enhanced production of every human protein, spurring advances in drug development Venlo, The Netherlands --- May 14, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and GENEART (Frankfurt, Entry Standard, G6A) announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 ... (Wed, 14 May 2008 06:52:06 GMT)

DJ HUGIN NEWS/QIAGEN and GENEART Partner to Commercialize Synthetic Mammalian Genes
- Complete set of mammalian genes is optimized & produced by GENEART and sold via QIAGEN's GeneGlobe web portal - Joint development and collaboration enables enhanced production of e.g. every human protein, spurring advances in drug development - Strategic partnership with QIAGEN to market standardized mammalian genes perfectly complements GENEART's existing business to tailor gene sequences for ... (Wed, 14 May 2008 06:52:15 GMT)

14.05.2008 - DJ HUGIN NEWS/QIAGEN and GENEART Partner to Commercialize Synthetic Mammalian Genes
Taeglich aktuelle Nachrichten, Berichte, Analysen und Interviews zu aktuellen Themen an der Boerse. Schwerpunkte sind deutsche Aktien, der Entry Standard und IPOs bzw. Boersengaenge. (Wed, 14 May 2008 07:02:46 GMT)

Craving something sweet? Blame it on your DNA
If you have a sweet tooth, it won't be found amongst your molars or canines. It's inserted in your DNA instead. (Wed, 14 May 2008 08:41:24 GMT)

23andMe and The Parkinson's Institute Announce Initiative to Advance Parkinson's Disease Research
MOUNTAIN VIEW & SUNNYVALE, Calif.----23andMe, a privately-held personal genetics company, and The Parkinson's Institute and Clinical Center today announced a research initiative under which Parkinson's Institute patients, with financial support from The Michael J. (Wed, 14 May 2008 09:30:00 GMT)

Trace Quantitative Analysis by Mass Spectrometry Covers All Aspects of the Use of Mass Spectrometry for Quantitation ...
DUBLIN, Ireland----Research and Markets has announced the addition of "Trace Quantitative Analysis by Mass Spectrometry" to their offering. (Wed, 14 May 2008 09:53:00 GMT)

23andMe and The Parkinson's Institute Announce Initiative to Advance Parkinson's Disease Research
23andMe, a privately-held personal genetics company, and The Parkinson's Institute and Clinical Center ("Parkinson's Institute") today announced a research initiative under which Parkinson's Institute patients, with financial support from The Michael J. Fox Foundation, will enroll in the 23andMe Personal Genome Service(TM) to support the development of advanced methods for clinical and ... (Wed, 14 May 2008 09:58:39 GMT)

Expanded Histology Methods Book Covers Processing Of Animal, Plant, And Microbial Tissues
For more than 25 years, the book Histological and Histochemical Methods has served as an established resource for researchers, students, and technologists in the biological and biomedical sciences who need to process normal or diseased tissues for microscopic analysis. A new edition, just released by Scion Publishing (http://www.scionpublishing. (Wed, 14 May 2008 10:13:30 GMT)

First use of DNA fingerprinting to identify viable embryos
Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. The technique, combined with sampling cells from blastocysts (the very early embryo) before implantation in the womb, opens the way to pin-pointing a handful of genes that could be ... (Wed, 14 May 2008 10:50:17 GMT)

Genetic variation linked to sugary food
A new study released today in the online edition of Physiological Genomics finds that individuals with a specific genetic variation consistently consume more sugary foods. The study offers the first evidence of the role that a variation in the GLUT2 gene - a gene that controls sugar entry into the cells - has on sugar intake, and may help explain individual preferences for foods high in sugar. (Wed, 14 May 2008 10:50:37 GMT)

Genetic Variation Linked To Preference Sugary Food
Individuals with a specific genetic variation consistently consume more sugary foods. The study offers the first evidence of the role that a variation in the GLUT2 gene -- a gene that controls sugar entry into the cells -- has on sugar intake, and may help explain individual preferences for foods high in sugar. (Wed, 14 May 2008 11:11:27 GMT)

DNA Fingerprinting Identifies Viable IVF Embryos
An international team of scientists has discovered a way of testing IVF embryos using DNA fingerprinting that could one day be used to select the ones that are more likely to implant successfully and grow to full term and thereby increase the likelihood of a successful pregnancy. (Wed, 14 May 2008 11:14:06 GMT)

Sweet tooth in the genes: study
Confectioners can take heart from these findings which suggest that in a health conscious world some people may always be tempted by the sweeter option. (Wed, 14 May 2008 11:28:23 GMT)

Enzo acquires Biomol's US assets
Enzo Biochem, Inc announced the acquisition of substantially all of the US based assets of Biomol International, LP, of Plymouth and all of the stock of its two-wholly-owned United Kingdom subsidiaries. (Wed, 14 May 2008 11:57:13 GMT)

MDS Analytical Technologies Introduces New Systems for Genomics Research
MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, announced today the release of three new molecular biology instruments designed to advance genomics and microgenomics discoveries for life sciences researchers. (Wed, 14 May 2008 12:00:00 GMT)

First Use Of DNA Fingerprinting To Identify Viable Embryos
Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilization and developed successfully to result in the births of healthy babies. The technique, combined with sampling cells from blastocysts before implantation in the womb, opens the way to pin-pointing a handful of genes that could be used to identify those ... (Wed, 14 May 2008 12:26:36 GMT)

Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
Rosetta Genomics , today announced it will release first quarter financial results on May 21, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss these results at 4:30 p.m. (Wed, 14 May 2008 12:30:00 GMT)

DNA fingerprinting breakthrough may send successful IVF rates soaring
Washington, May 14 : Australian researchers have used a technique, DNA fingerprinting, for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. (Wed, 14 May 2008 13:30:46 GMT)

Intrexon uses DNA to control biotherapeutics
BLACKSBURG, VA—A lot of people do not see DNA for what it is, says Robert Beech, CEO of Intrexon. “It is most importantly a way of controlling the production of biomolecules,” he says. Using nature’s own DNA control systems, Intrexon hopes to help companies make safer, more effective drugs. (Wed, 14 May 2008 16:14:36 GMT)

Personalized medicine startup Proventys lands $5.65M funding, names CEO
DURHAM, NC—Proventys Inc., a personalized medicine knowledge service provider, has secured $5.65M in Series A1 financing. Life sciences-focused venture capital firm Burrill & Company led the investment in Proventys. (Wed, 14 May 2008 16:29:36 GMT)

President of Panama and Head of Microsoft Research Address Scientific Research Opportunities in Latin America
Microsoft Research today kicked off its fourth annual Latin American Academic Summit, where the Panamanian President Martin Torrijos Espino welcomed nearly 300 academic, government and industry research leaders from 18 Latin American countries to the City of Knowledge research park. (Wed, 14 May 2008 17:00:00 GMT)

Glutton for Sugar? Genes Get Heap of Blame
A variation in the GLUT2 gene may be linked to sugary diets in people with and without diabetes, a Canadian study shows. (Wed, 14 May 2008 17:10:50 GMT)

San Francisco
PANAMA CITY , May 14 /PRNewswire-FirstCall/ -- Microsoft Research today kicked off its fourth annual Latin American Academic Summit, where the Panamanian President Martin Torrijos Espino welcomed nearly 300 academic, government and industry research leaders from 18 Latin American countries to the City of Knowledge research park. (Wed, 14 May 2008 18:29:54 GMT)

CombiMatrix Corporation Reports First Quarter 2008 Financial Results
MUKILTEO, Wash., May 14, 2008 -- CombiMatrix Corporation today reported its financial results for the three months ended March 31, 2008. Key highlights for the first quarter include the following: (Wed, 14 May 2008 20:05:00 GMT)

Join the computing hunt for super-rice
A team of researchers at the University of Washington are putting a genomics project on the World Community Grid in the computational search for strains of rice that have traits like higher yields, disease resistance and a wider range of nutrients. (Wed, 14 May 2008 20:29:42 GMT)

Better Baby-Making: Picking the Healthiest Embryo for IVF [News]
There's new hope for the more than 7 million American women (and their partners) who long for a child and are plagued by infertility. Australian researchers have developed a method for screening embryos created through in vitro fertilization (IVF) to select the ones that have the best shot of developing into healthy babies. [More] (Wed, 14 May 2008 21:42:29 GMT)

Major Sudden Cardiac Arrest Risk Stratification Trials Unveiled
Medtronic, Inc. (NYSE: MDT), along with several partners, today announced details of several major clinical trials aimed at developing and validating new and innovative risk stratification tools to predict which post-myocardial infarction ... (Wed, 14 May 2008 22:28:40 GMT)

Qiagen and Geneart join hands to commercialize synthetic genes
Qiagen and Geneart have announced their collaboration to develop, produce and commercialize a new product line for the enhanced production of all 35,000 human proteins. (Thu, 15 May 2008 01:30:08 GMT)

Alpha Innotech Reports Strong First Quarter International Revenue Growth
Alpha Innotech Corp. (OTCBB:APNO), a leading provider of bioanalytical systems for drug discovery and life science research, today reported financial results for the quarter ending March 31, 2008. (Thu, 15 May 2008 01:47:08 GMT)

IBM's Answer to the Food Crisis
Big Blue's World Community Grid and a University of Washington team are using PCs globally to develop better strains of rice (Thu, 15 May 2008 05:29:11 GMT)

IBM's Answer to the Food Crisis
Big Blue's World Community Grid and a University of Washington team are using PCs globally to develop better strains of rice (Thu, 15 May 2008 06:42:48 GMT)

CombiMatrix Corp. of Mukilteo looks for capital
MUKILTEO -- CombiMatrix Corp. warned it could be out of money by the fall, despite a 75 percent increase in the biotechnology firm's revenue during the first quarter. (Thu, 15 May 2008 07:24:14 GMT)

E-clinical Trial Solutions Markets Show Exciting Potential in Europe
LONDON----Considerable opportunities exist for e-clinical trial solutions. However, pharmaceutical companies should be convinced about the need for these solutions and the benefits of investing in them, as the entire industry is in a cost-cutting phase. (Thu, 15 May 2008 07:55:00 GMT)

E-clinical Trial Solutions Markets Show Exciting Potential in Europe
15/05/2008 07:55:00 Business Wire Considerable opportunities exist for e-clinical trial solutions. However, pharmaceutical companies should be convinced about the need for these solutions and the benefits of investing in them, as the entire industry is in a cost-cutting phase. (Thu, 15 May 2008 08:10:04 GMT)

E-clinical Trial Solutions Markets Show Exciting Potential in Europe
Considerable opportunities exist for e-clinical trial solutions. However, pharmaceutical companies should be convinced about the need for these solutions and the benefits of investing in them, as the entire industry is in a cost-cutting phase. E-clinical technology vendors, with highly scalable and cost-effective services and solutions, are well positioned to capture the market. (Thu, 15 May 2008 08:28:41 GMT)

Examine the World Spectrometers and Spectrophoto/Fluorometers Markets
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue. (Thu, 15 May 2008 09:00:00 GMT)

Researchers Discover Architecture For Fundamental Processes Of Life - Universite De Montreal Study
A team of Canadian researchers has completed a massive survey of the network of protein complexes that orchestrate the fundamental processes of life. (Thu, 15 May 2008 09:12:08 GMT)

Link Discovered Between Genetic Variation And Desire For Sugary Food
A new study released in the online edition of Physiological Genomics finds that individuals with a specific genetic variation consistently consume more sugary foods. The study offers the first evidence of the role that a variation in the GLUT2 gene - a gene that controls sugar entry into the cells - has on sugar intake, and may help explain individual preferences for foods high in sugar. (Thu, 15 May 2008 10:13:08 GMT)

Stellar Pharmaceuticals Inc. Announces Revenue Increased by 25.7% Gross Profits up by 50.9%
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF) announced that for the three month period ended March 31, 2008, total operating revenues improved by 25.7%. This improvement was driven by increased international sales for NeoVisc, while cost of products sold for the period improved to 24.3% of product sales compared to 31.4% of product sales in the same period in 2007. (Thu, 15 May 2008 11:30:00 GMT)

Signature Genomic Laboratories Signs Long-Term Supply Agreement with Agilent Technologies for Oligo Microarrays
SPOKANE, Wash. & SANTA CLARA, Calif.----Signature Genomic Laboratories, LLC and Agilent Technologies, Inc. , today announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays based on the Signature-designed SignatureChip Oligo SolutionTM to Signature and its customers. (Thu, 15 May 2008 13:15:00 GMT)

Examine Computational Methods for Mass Spectrometry Proteomics
DUBLIN, Ireland----Research and Markets has announced the addition of "Computational Methods for Mass Spectrometry Proteomics" to their offering. (Thu, 15 May 2008 13:20:00 GMT)

Signature Genomic Laboratories Signs Long-Term Supply Agreement with Agilent Technologies for Oligo Microarrays
Signature Genomic Laboratories, LLC (Signature) and Agilent Technologies, Inc. (NYSE: A), today announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays based on the Signature-designed SignatureChip Oligo Solution(TM) (SignatureChipOS(TM)) to Signature and its customers. (Thu, 15 May 2008 13:51:06 GMT)

Glutton for Sugar? Genes Get Heap of Blame
A variation in the GLUT2 gene may be linked to sugary diets in people with and without diabetes, a Canadian study shows. (Thu, 15 May 2008 14:00:06 GMT)

Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays
SANTA CLARA, Calif. & SPOKANE, Wash.----Agilent Technologies Inc. and Signature Genomic Laboratories LLC today announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays to Signature and its customers based on the Signature-designed SignatureChip Oligo Solution . (Thu, 15 May 2008 15:23:00 GMT)

Agilent Technologies, Signature Genomic Laboratories Announce . Long-Term Supply Agreement for Oligo Microarrays
Long-Term Supply Agreement for Oligo Microarrays 15/05/2008 15:23:00 Business Wire US9011661082 Agilent Technologies Inc. (Thu, 15 May 2008 15:40:04 GMT)

Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays
Agilent Technologies Inc. (NYSE:A) and Signature Genomic Laboratories LLC (Signature) today announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays to Signature and its customers based on the Signature-designed SignatureChip Oligo Solution (SignatureChipOS). Terms of the agreement were not disclosed. (Thu, 15 May 2008 15:47:34 GMT)

Connecting cancer genes
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations. (Thu, 15 May 2008 16:06:13 GMT)

Immune cells kill foes by disrupting mitochondria 2 ways
BOSTON, Mass. (May 15, 2008)—When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. (Thu, 15 May 2008 16:06:21 GMT)

Immune Cells Kill Foes by Disrupting Mitochondria Two Ways
T cells can initiate cellular suicide, also known as apoptosis, by a previously unrecognized pathway that starts with the destruction of a key enzyme in mitochondria, the power plant of the cell. (Thu, 15 May 2008 16:24:31 GMT)

Immune cells kill foes by disrupting mitochondria 2 ways
When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. A new study shows T cells can initiate cellular suicide, also known as programmed cell death or apoptosis, by a previously unrecognized pathway that starts with the destruction of a key enzyme in mitochondria, the power ... (Thu, 15 May 2008 16:35:36 GMT)

Coughing? Can I See Your DNA, Please? [Extreme Tech]
You're a stressed-out intensive care unit (ICU) doctor, trying desperately to save the lives of a score of patients under your care. Most of them are on ventilators, and you know that a good number of such patients will go on to develop pneumonia, upping their risk of death. You want to treat them, and fast. [More] (Thu, 15 May 2008 17:57:26 GMT)

An ancient protein balances gene activity and silences foreign DNA in bacteria
NEW YORK, May 15, 2008 – Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don’t carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. (Thu, 15 May 2008 18:05:47 GMT)

An ancient protein balances gene activity and silences foreign DNA in bacteria
Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don`t carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is non -coding junk ... (Thu, 15 May 2008 18:20:17 GMT)

An Ancient Protein Balances Gene Activity and Silences Foreign DNA in Bacteria
A combination of genomics and proteomics yields a surprising finding. (Thu, 15 May 2008 18:24:32 GMT)

MDS Analytical Technologies Introduces New Systems For Genomics Research
MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life sciences research, announced the release of three new molecular biology instruments designed to advance genomics and microgenomics discoveries for life sciences researchers (Thu, 15 May 2008 19:03:13 GMT)

Center to Hold Personal Genomics Seminar June 10
The seminar, "The Molecular Full Monty: Personal Genomes, Personal Health" will address questions such as: What can gene tests tell you about your future health, and what are their limitations? Is more information always useful and desirable? How do consumers use their results? (Thu, 15 May 2008 19:28:18 GMT)

Agilent, Signature Genomic Ink Oligo Microarray Supply Agreement
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 15 May 2008 19:44:49 GMT)

Theranostics Health Signs Research Collaboration Agreement
Theranostics Health today announced that it has entered into a three-year master research collaboration agreement with Duke University. (Thu, 15 May 2008 20:49:00 GMT)

Differential Proteomics Wins 2008 North of Boston Business Plan Competition
Beverly Company WINS $10,000 first prize; Flavrz of Gloucester second; Enterprise Homes LLC of Andover third. (Thu, 15 May 2008 21:18:00 GMT)

Cash-short Metamorphix hopes new Petco deal will buy time
Executives at Metamorphix Inc. are touting successes such as a deal to sell its dog breed DNA test through Petco stores that they say could help the struggling animal genomics company break even this year. (Thu, 15 May 2008 23:12:48 GMT)

A First In Fertility Research: The Use Of DNA Fingerprinting To Identify Viable Embryos
Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. (Fri, 16 May 2008 08:10:38 GMT)

Study Finds That Those With A GLUT2 Gene Variation Consistently Consume More Sugars, Regardless Of Age Or Sex
A new study released in the online edition of Physiological Genomics finds that individuals with a specific genetic variation consistently consume more sugary foods. The study offers the first evidence of the role that a variation in the GLUT2 gene - a gene that controls sugar entry into the cells - has on sugar intake, and may help explain individual preferences for foods high in sugar. (Fri, 16 May 2008 09:11:18 GMT)

Connecting Cancer Genes - Study Implicates 350 Gene Regions In Cancer Development In The Mouse, UK
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations. The study found just over 10,000 mutations in total, which together implicate almost 350 regions in the mouse genome in cancer formation. (Fri, 16 May 2008 09:11:28 GMT)

23andMe And The Parkinson's Institute Announce Initiative To Advance Parkinson's Disease Research
23andMe, a privately-held personal genetics company, and The Parkinson's Institute and Clinical Center ("Parkinson's Institute") announced a research initiative under which Parkinson's Institute patients, with financial support from The Michael J. (Fri, 16 May 2008 10:10:38 GMT)

Theranostics Health signs collaboration agreement with Duke University
Theranostics Health has entered into a three-year master research collaboration agreement with Duke University. (Fri, 16 May 2008 10:14:34 GMT)

Solving The Mystery Of Disease Origins: St. Louis Encephalitis
Before West Nile virus arrived in this country, we had (and still have) a home-grown relative of this pathogen. An epidemic of unknown origin exploded around St. Louis, Missouri in the autumn of 1933, a disease that is now known to be transmitted by mosquitoes from birds to people. Now, a new analysis of the genome of St. (Fri, 16 May 2008 11:13:08 GMT)

Invitrogen Launches Cell Therapy Business Unit
CARLSBAD, Calif.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, today announced its further commitment to advancing the clinical cell therapy field by creating a new business unit within the company focused on the specific needs of that market. (Fri, 16 May 2008 12:00:00 GMT)

Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology ...
Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics and therapeutics, today announced that it will present multiple posters at the upcoming ASCO annual meeting in Chicago. (Fri, 16 May 2008 12:30:00 GMT)

Invitrogen Launches Cell Therapy Business Unit
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced its further commitment to advancing the clinical cell therapy field by creating a new business unit within the company focused on the specific needs of that market. (Fri, 16 May 2008 12:50:13 GMT)

India looks to nanotechnology to boost agriculture
The Indian government is looking towards nanotechnology as a means of boosting agricultural productivity in the country. In a report released in April, the Planning Commission of India recommends nanotechnology research and development (R&D) should become one of six areas for investment. (Fri, 16 May 2008 13:45:22 GMT)

NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO
The following news tips are based on abstracts or poster presentations at the annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 – June 3, 2008. (Fri, 16 May 2008 14:50:35 GMT)

Scientists on trail of way to predict NF1 tumor growth and associated malignant tumors
CINCINNATI – Researchers at Cincinnati Children’s Hospital Medical Center have identified proteins that could be biological markers of non-cancerous tumors that affect peripheral nerves called Neurofibromatosis 1 (NF1), which can change to a highly aggressive cancer called Malignant Peripheral Nerve Sheath Tumors (MPNST). This new finding could help resolve a current lack of reliable ways to ... (Fri, 16 May 2008 16:05:35 GMT)

B-Roll Footage - Treatment
The NCI Press Office maintains a collection of B-roll video depicting various areas of research at NCI. NCI B-roll is available to any accredited news organization. (Fri, 16 May 2008 16:36:23 GMT)

Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that the company will feature its Ziplex Automated Gene-Expression System at Biomarker World Congress, booth 16. (Fri, 16 May 2008 17:18:00 GMT)

Immune Cells Kill Foes By Disrupting Mitochondria Two Ways
T cells can initiate cellular suicide, also known as apoptosis, by a previously unrecognized pathway that starts with the destruction of a key enzyme in mitochondria, the power plant of the cell. (Fri, 16 May 2008 20:26:26 GMT)

Former CMS Administrator: "'Blunt Instrument' Policies an Increasingly Bad Fit in Era of Personalized Health Care"
Recent legislative emphasis on price negotiation and physician reimbursement as a means to reduce health care costs are nothing more than "short term patches" that hold no potential for truly reforming health care, former Centers for Medicare and Medicaid Services Administrator Dr. (Fri, 16 May 2008 20:37:00 GMT)

San Francisco
ORLANDO, Fla. ( Map ) - ORLANDO, Fla. , May 16 /PRNewswire-FirstCall/ -- Recent legislative emphasis on price negotiation and physician reimbursement as a means to reduce health care costs are nothing more than "short term patches" that hold no potential for truly reforming health care, former Centers for Medicare and Medicaid Services (CMS) Administrator Dr. Mark McClellan told hundreds of ... (Fri, 16 May 2008 21:35:55 GMT)

Technology Lags In Helping Health
Genome mapping and digital records have helped the medical industry, but health technology has a long way to go. (Fri, 16 May 2008 22:36:07 GMT)

Combination Of Genomics And Proteomics Yields A Surprising Finding: Silencing Foreign DNA In Bacteria
Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don't carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. (Sat, 17 May 2008 08:12:18 GMT)

Rosetta Genomics To Present Multiple Posters At The 44th Annual Meeting Of The American Society Of Clinical Oncology ...
Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced that it will present multiple posters at the upcoming ASCO annual meeting in Chicago. The company also has three publication only abstracts available on ASCO's website. The event will take place from May 30 to June 3 at the McCormick Place, Chicago, Illinois. (Sat, 17 May 2008 08:13:19 GMT)

Roswell Park workshop plants seeds for growth of technology
Even the best inventions need a strong business model in order to flourish in the marketplace. (Sat, 17 May 2008 10:58:14 GMT)

Dirac Scientific Computing LLC
Dirac Scientific Computing LLC is an emergent services and products provider in the areas of cheminformatics, bioinformatics, research informatics, drug discovery and scientific computing for pharmaceutical R&D, life sciences research and material design industry and other related fields. (Sat, 17 May 2008 18:13:42 GMT)

Time to diversify economy? Experts weigh in
The Valley is too dependent on housing, growth. (Sun, 18 May 2008 01:56:07 GMT)

Annika Sorenstam to keep swinging for Cutter & Buck
Annika Sorenstam is getting out of professional golf, but she'll still be in Cutter & Buck. The Annika line of women's golf apparel... (Sun, 18 May 2008 07:36:14 GMT)

Immune Cells Kill Foes By Disrupting Mitochondria 2 Ways
When killer T cells of the immune system encounter virus-infected or cancer cells, they unload a lethal mix of toxic proteins that trigger the target cells to self-destruct. (Sun, 18 May 2008 08:11:31 GMT)

Geneticists Trace The Evolution Of St. Louis Encephalitis
Researchers have sequenced the entire genetic code of 23 strains of Flavivirus, the virus that causes St. Louis encephalitis, to understand its evolutionary history. This study, published in Molecular Phylogenetics and Evolution, found that a single mutation made the virus pathogenic to humans and that the North and South American strains divided about 116 years ago. (Sun, 18 May 2008 08:26:26 GMT)

New Tool To Understand Evolution Of Multi-domain Genes Developed
Computational biologists have for the first time tackled the dilemma of how to study the ancestry of multidomain genes, which encode an important class of proteins called multidomain proteins that are crucial to human health. They found that standard methods for analyzing gene evolution, are critically flawed when applied to multidomain genes, mutations of which often are associated with cancers. (Sun, 18 May 2008 20:26:58 GMT)

Pfizer and Peter MacCallum support the future of cancer research in Australia
Australia's reputation for excellence in cancer research has been strengthened with the launch of the Peter MacCallum Pfizer Translational Oncology Research Collaborative Hub (TORCH) at the Peter MacCallum Cancer Centre, by the Minister for Innovation, Industry, Science and Research, Senator the Hon. Kim Carr. (Sun, 18 May 2008 23:46:25 GMT)

DNA Sequencing in a Snap
An innnovative approach could target hard-to-sequence areas. (Mon, 19 May 2008 04:05:44 GMT)

A new poppy variety to check drug abuse
A poppy plant that is difficult to extract morphine from? That is what scientists at the Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, have developed in order to combat abuse of drugs produced from poppy. (Mon, 19 May 2008 05:18:36 GMT)

Pace University science lab building to get $7.2 million overhaul
As the number of enrolled science majors continues to increase, Pace University's Pleasantville campus has begun to plan the renovation of its science building - work that will be paid for by a grant from New York state and a donation from a Pace graduate's family foundation. (Mon, 19 May 2008 06:38:00 GMT)

New Online Tutorials on FlyBase, WormBase and Mouse Genome Informatics (MGI) Resources
Comprehensive tutorials on the model organism bioinformatics databases FlyBase, WormBase and MGI enable researchers to quickly and effectively use these invaluable resources. (Mon, 19 May 2008 07:01:00 GMT)

UNCG studies benefits of food at new center on N.C. Research Campus
By Emily Ford Salisbury Post KANNAPOLIS — Everyone knows about vitamins and minerals. What they're called, where to find them and what they do. We ... (Mon, 19 May 2008 07:37:16 GMT)

Clinical Data Launches Genetic Test For Hypertrophic Cardiomyopathy (HCM)
Clinical Data, Inc. (NASDAQ:CLDA) announced at the Heart Rhythm Society's annual meeting, 2008 Heart Rhythm, that its PGxHealthTM division is adding genetic testing for Hypertrophic Cardiomyopathy (HCM) to its FAMILION® family of genetic tests for cardiac syndromes. (Mon, 19 May 2008 10:12:45 GMT)

Calibrant Biosystems to Present at Tenth Annual C21 BioVentures Conference
GAITHERSBURG, Md.----Calibrant Biosystems, a biotechnology company specializing in proteomics-based target drug discovery and development, today announced that Michael L. Salgaller, PhD, Chief Operating Officer, will present at the 10th Annual C21 BioVentures Conference on Wednesday, May 21, 2008 at 2:45 p.m. (Mon, 19 May 2008 11:30:00 GMT)

Calibrant Biosystems to Present at Tenth Annual C21 BioVentures Conference
Calibrant Biosystems, a biotechnology company specializing in proteomics-based target drug discovery and development, today announced that Michael L. Salgaller, PhD, Chief Operating Officer, will present at the 10th Annual C21 BioVentures Conference on Wednesday, May 21, 2008 at 2:45 p.m. Eastern Time. The conference will be held May 21-22, 2008 at the Meritage Resort, Napa, California. (Mon, 19 May 2008 11:48:29 GMT)

Korea NIH Expands KARE Project with Second Affymetrix Technology Order
Affymetrix Inc. (Nasdaq:AFFX) today announced that the Republic of Korea's National Institute of Health (NIH) and Center for Disease Control and Prevention is expanding the Korean Association Resource (KARE) project and using the Affymetrix Genome-Wide Human SNP Array 6.0 to analyze 13,000 additional samples. (Mon, 19 May 2008 12:00:00 GMT)

Itanium(R) Solutions Alliance Announces 2008 Innovation Award Winners
SAN RAMON, Calif.----The Itanium® Solutions Alliance today announced the winners of its second annual Itanium Solutions Alliance Innovation Award. The global award program recognizes innovation and achievement using Intel® Itanium® processor technology to solve complex humanitarian, business and entrepreneurial challenges. (Mon, 19 May 2008 12:01:00 GMT)

Potential To Predict NF1 Tumor Growth And Associated Malignant Tumors
Researchers at Cincinnati Children's Hospital Medical Center have identified proteins that could be biological markers of non-cancerous tumors that affect peripheral nerves called Neurofibromatosis 1 (NF1), which can change to a highly aggressive cancer called Malignant Peripheral Nerve Sheath Tumors (MPNST). (Mon, 19 May 2008 12:12:48 GMT)

News Based On Abstracts Or Poster Presentations At The Annual Meeting Of The American Society Of Clinical Oncology ...
The annual meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, Illinois, May 30 - June 3, 2008.Study Tracks a Biomarker for Early Detection of Malignant Pleural MesotheliomaAbstract # 11074: Plasma osteopontin is an early detection and prognostic marker in malignant pleural mesotheliomaNYU Cancer Institute's Harvey Pass, M.D. (Mon, 19 May 2008 12:12:58 GMT)

Itanium(R) Solutions Alliance Announces 2008 Innovation Award Winners
The Itanium(R) Solutions Alliance today announced the winners of its second annual Itanium Solutions Alliance Innovation Award. The global award program recognizes innovation and achievement using Intel(R) Itanium(R) processor technology to solve complex humanitarian, business and entrepreneurial challenges. Each winner receives a $50,000 U.S. cash prize or can make a charitable donation to an ... (Mon, 19 May 2008 12:50:20 GMT)

New York Biotechnology Association Releases The 2008 State of the Industry Report
New York Biotechnology Association 17th Annual Meeting--The New York State Biotechnology Association (NYBA), the voice of New York State's biotechnology industry, today released its 2008 State of the Industry Report. The 2008 State of the Industry Report provides data on the economic and financial health of the multi-billion biotechnology industry in New York State, which currently ranks fifth ... (Mon, 19 May 2008 13:47:29 GMT)

An Ancient Protein Balances Gene Activity And Silences Foreign DNA In Bacteria
Compared to humans, bacteria have a much tidier genome. The tiny microorganisms pack their genes closely together, and don't carry around a lot of extraneous DNA, so-called junk DNA that fills in the gaps between genes. Some 90 percent of the complete genome sequence of the bacteria E. coli contains sequences of DNA that code for protein, while 90 percent of the human genome is non-coding junk ... (Mon, 19 May 2008 14:12:17 GMT)

The 10th Annual C21 BioVentures Presenter Profile for Calibrant Biosystems
NAPA, Calif.----10th Annual C21 BioVentures takes place May 20 - 22, 2008 at The Meritage Resort at Napa in Napa, CA. Listed below is the 10th Annual C21 BioVentures presenter profile for Calibrant Biosystems. (Mon, 19 May 2008 14:36:00 GMT)

TRADE NEWS: Clone-Based Sequencing, Agilent Technologies' CGH Microarrays Used to Discover Structural Variation of ...
SANTA CLARA, Calif.----A group of researchers has provided new insight into processes shaping the human genome. They used a clone-based method to build a comprehensive, fine-scale map of structural variation in eight human genomes from diverse geographic ancestry. (Mon, 19 May 2008 15:00:00 GMT)

The 10th Annual C21 BioVentures Presenter Profile for Calibrant Biosystems
10th Annual C21 BioVentures takes place May 20 - 22, 2008 at The Meritage Resort at Napa in Napa, CA. Listed below is the 10th Annual C21 BioVentures presenter profile for Calibrant Biosystems. For in-depth information about the event, visit http://www.techvision.com/c21/ (Mon, 19 May 2008 15:04:32 GMT)

South Korea's NIH Expands Human Disease Study with Affy Microarray Buy
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 19 May 2008 15:14:59 GMT)

NSF To Award $20M Annually for Bioinformatics Through 2010
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Mon, 19 May 2008 15:15:19 GMT)

TRADE NEWS: Clone-Based Sequencing, Agilent Technologies' CGH Microarrays Used to Discover Structural Variation of ...
A group of researchers has provided new insight into processes shaping the human genome. They used a clone-based method to build a comprehensive, fine-scale map of structural variation in eight human genomes from diverse geographic ancestry. Employing a variety of technologies for validation and characterization, including Agilent CGH microarrays, they identified 1,695 sites of structural ... (Mon, 19 May 2008 15:32:53 GMT)

AnaSpec Introduces ClearPoint™ Heavy Isotope-Labeled Peptides AnaSpec Inc. Posted on: 16 May 08
San Jose, CA – May 16, 2008 AnaSpec, one of the world’s leading providers of custom and catalog peptides, has introduced ClearPoint™ Peptides, heavy isotope-labeled peptides for absolute quantitation (AQUA) of proteins. (Mon, 19 May 2008 16:11:57 GMT)

Study Implicates 350 Gene Regions In Cancer Development In The Mouse
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations. The study found just over 10,000 mutations in total, which together implicate almost 350 regions in the mouse genome in cancer formation. Fifty of these regions correspond to genes known to be involved in human ... (Mon, 19 May 2008 16:27:37 GMT)

Translational Genomics Research Institute near ID of gene that increases melanoma risk
Researchers at the Translational Genomics Research Institute are closing in on a gene that could help explain why some people are more prone to getting melanoma than others. (Mon, 19 May 2008 16:53:10 GMT)

Evolution of St. Louis encephalitis traced
NEW YORK, May 19 (UPI) -- U.S. geneticists say they have traced the evolution of St. Louis encephalitis and determined the origin of the disease. (Mon, 19 May 2008 17:14:26 GMT)

MagSense to Exhibit Its Scientific and Clinical Applications at International Magnetic Carriers Conference
MagSense Life Sciences Inc, a leading developer and manufacturer of magnetic separation technologies, announced it will be participating in the 7th International Conference on the Scientific and Clinical Applications of Magnetic Carriers, being held May 21-24, 2008 in Vancouver, BC, Canada. (Mon, 19 May 2008 18:00:00 GMT)

Researchers Close In On New Melanoma Gene
It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others (Mon, 19 May 2008 18:18:13 GMT)

'Gene Stream' students co-author journal article
"Being an undergraduate co-author on a cover story is rather extraordinary," says St. Olaf Professor of Biology Eric Cole. "It's also a nice demonstration of what we hoped students would achieve through participation in the Gene Stream" -- a three-year interdisciplinary project supported by a $540,000 grant. (Mon, 19 May 2008 19:15:53 GMT)

Invitrogen Advances Next Generation Sequencing Workflows
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the SequalPrep(TM) System; a complete sample enrichment and normalization solution for next generation sequencing technologies that consists of the SequalPrep(TM) Long PCR Kit and the SequalPrep(TM) Normalization Plate (96) Kit. (Mon, 19 May 2008 20:33:50 GMT)

U.S. patent office grants re-examination of RNA splicing microarray patent on behalf of Jivan
Jivan Biologics, Inc. announced today that the United States Patent and Trademark Office has ordered the re-examination of U.S. Patent No. 6,881,571. The serial number for the reexamination is 90/009,017. (Mon, 19 May 2008 22:31:57 GMT)

Mapping of prostate cancer genes opens the door to new treatments
Genetic changes during the initiation and progression of prostate cancer have eluded scientists to date. Now for the first time researchers have identified a specific gene expression profile of prostate cancer stem cells, with important implications for future treatments. The findings, published in BioMed Central's open access journal Genome Biology, revealed 581 genes that are differentially ... (Mon, 19 May 2008 23:20:48 GMT)

Patterns: Craving Sweets? It May Be in Your Genes
Researchers have found that people with a common variant of a gene that helps the body handle sugar are more likely to crave foods like soda and cake. (Tue, 20 May 2008 02:02:31 GMT)

Profits elusive, but biotech still lures investors
The biotechnology industry has yet to turn a profit but investors are pouring billions into the development of genetically engineered drugs needed by major pharmaceutical companies to reinvigorate their product lines. (Tue, 20 May 2008 04:05:31 GMT)

Previous 1 2 3 4 5 Next